August 15, 2017 / 8:50 AM / 2 years ago

BRIEF-Jiangsu Hengrui Medicine and unit plans clinical trail for new drug SHR0302

Aug 15(Reuters) - Jiangsu Hengrui Medicine Co Ltd :

* Says it and unit plans to start clinical trail for new drug SHR0302, which is a kind of selective depressant used for treatment of rheumatoid arthritis

Source text in Chinese: goo.gl/N3qUWA

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below